Method of manufacturing disposable and/or replenishable transdermal drug applicators

• US 4,731,926 A
• Filed: 12/10/1985
• Issued: 03/22/1988
• Est. Priority Date: 02/19/1985
• Status: Expired due to Term

• Current Assignee: Drug Delivery Systems Incorporated
• Original Assignee: Drug Delivery Systems Incorporated
• Inventors: Sibalis, Dan
• Primary Examiner(s): Goldberg, Howard N.
• Assistant Examiner(s): Arbes, Carl J.
• Application Number:
  US06/807,234
• Time in Patent Office: 833 Days
• Field of Search: 128/640, 128/641, 128/798, 29/877, 29/878, 604/20
• US Class Current: 29/877
• CPC Class Codes: A61M 37/00 Other apparatus for introducing media into the body for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30; Percutany, i.e. introducing medicines into the body by diffusion through the skin salt baths A61H33/04
• CPC Class Codes: A61N 1/0436 Material of the electrode
• CPC Class Codes: A61N 1/044 Shape of the electrode
• CPC Class Codes: A61N 1/0448 Drug reservoir
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428
• CPC Class Codes: Y10T 29/4921 with bonding

Abstract

Applicators for the electrophoretic and/or electro-osmotic deposition of a medicament across the skin and into the blood stream. The applicator includes a plurality of drug reservoir electrodes, a battery, a plurality of folded members each having an electrically conductive coating on a flexible, non-conductive substrate in electrical contact with the batttery and the drug reservoir electrodes, electrical current conditioning means, a cover adhesively secured to the applicator, and a release liner covering and protecting the drug reservoirs until use. A method of manufacturing the applicator is set forth.

Claims

1. A method of manufacturing a transdermal drug applicator which is adapted to be electrically activated, comprising the steps of:

(a) applying conductive coated areas to the first surface of flexible, non-conductive substrate having first and second surfaces for use in said drug applicator, said coated areas and said substrate forming a one-piece member;

(b) folding by about 180 degree portions of said one-piece member with said conductive coated areas so as to form folded top side and bottom side portions and to provide electrical conductors leading between said top side and bottom side portions;

(c) applying at least one occlusive adhesive dam to the surface of another substrate containing thereon a coated release agent;

(d) adding at least one drug resrvoir to said surface of said another substrate adjacent to said dam;

(e) joining said at least one drug reservoir to a portion of at least one of said coated areas of said electrical conductors;

(f) joining together in registration said bottom side of said one-piece member and said another substrate to form a sandwiched construction in which said at least one drug reservoir and said occlusive dam are contained between bottom side of said one-piece member and said another substrate;

(g) applying a conformal cover having an adhesive coated surface over said second side of said flexible substrate of said folded one-piece member so as to enclose and protect said transdermal drug applicator.

2. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 1, further comprising the step of applying an adhesive coating to said second surface of said flexible substrate.

3. The method of manufacturing a transdermal drug applicator which is adapt to be electrically activated according to claim 1, wherein at least one of conductive coated areas comprises carbon powder.

4. The method of manufacturing a transdermal drug applicator which is electrically activated according to claim 3, wherein said carbon powder contains a depolarizing agent.

5. The method of manufacturing a transdermal drug applicator which is electrically activated according to claim 3, wherein at least one of said conductive coated areas comprises a noble metal.

6. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 1, further comprising the steps of adding a battery having terminals;

extending one of said conductive coated areas to one terminal of said battery;

extending the other terminal of said battery to another of said coated areas; and

of electrically connecting said another said coated area so as to form an electrical circuit when said applicator is applied to the skin.

7. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 6, further comprising the step of forming a plurality of negative and positive battery electrodes on said plastic substrate so as to form a plurality of battery cells;

and electrically connecting the last negative and positive battery terminals to conductive surfaces on said plastic substrate.

8. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 7, further comprising the step of interconnecting said positive and negative terminals of said battery cells in series by means of a conductive adhesive.

9. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 8, further comprising the step of folding said flexible substrate along a plurality of fold lines so as to form said plurality of battery cells, and placing in between the terminals of each said cell a gelled battery electrolyte impregnated thermoplastic separator, and heat sealing the periphery of said cells.

10. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 9, further comprising the step of adding an electronic current conditioning means in series with said battery on the positive terminal side of said battery.

11. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 10, wherein all of the electrical connections within said drug applicator are made by the use of conductive flexible adhesives.

15. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 6, further including the steps of adding another drug reservoir to said surface of said another substrate with said dam separating said another drug reservoir from said drug reservoir;

and joining said another drug reservoir to a portion of another of said coated areas so as to form said electrical circuit.

16. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 6, further including the steps of forming an aperture in said conformal cover so as to make a well area adjacent to said coated area and said another coated area at said topside of said flexible member;

and wherein said battery is a reusable battery adapted to be removably placed in said well area.

17. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 16, wherein said reusable battery is a disc battery having terminals on opposite sides thereof.

18. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 16, further including the step of adding timing and programmable control means with said reusable battery so as to make a reusable power and control unit adapted to be removably placed in said well of said applicator.

19. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 6, wherein said battery includes a pair of positive and negative sheet electrodes.

20. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 19, wherein said pair of electrodes is a plurality of electrodes forming a plurality of battery cells connected in series.

21. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 19, wherein said positive and negative electrodes are zinc and carbon electrodes, respectively.

22. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 6, wherein said at least one drug reservoir is on said one terminal of said battery and said another drug reservoir is on said other terminal of said battery, and wherein said at least one drug reservoir is a plurality of drug reservoirs and said another drug reservoir is a plurality of drug reservoirs.

23. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 22, wherein said drug reservoirs include gels.

24. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 23, wherein said gels are reinforced by scrims.

25. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 23, wherein said drug reservoirs include open cell foam material impregnated with said gels.

26. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 22, further including a semi-permeable membrane positioned in juxtaposition to said drug reservoirs, said semi-permeable membrane having seals corresponding to said dam so as define particular drug zones.

27. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 26, wherein said drug zones containing drugs of different concentrations.

28. The method of manufacturing a transdermal drug applicator which is adapted to be electrically activated according to claim 26, wherein said drug zones contain drugs of different compositions.

31. The method of manufacturing a transdermal drug applicator according to claim 1 or 29, wherein said another substrate is a release liner of said drug applicator.

32. The method of manufacturing a transdermal drug applicator according to claim 1 or 29, wherein said at least one drug reservoir having a scrim member so as to at least provide reinforcing of drug reservoir.

12. A method for making a replaceable disposable drug reservoir for a transdermal drug applicator adapted to be electrically powered, comprising the steps of:

a. providing a release coated substrate;

b. depositing on said substrate a plurality of occlusive adhesive dams made of a nonconductive material impervious to fluids to define a plurality of drug reservoir compartments;

c. laminating an open cell foam material to said substrate over said occlusive adhesive dams so as to cause said nonconductive material to penetrate and fill the full thickness of said open cell foam; and

d. filling said plurality of drug reservoir compartments with various gelled drug mixtures.

13. The method of manufacturing a transdermal drug applicator according to claim 12, further comprising the step of laminating together said replaceable drug reservoir with another drug reservoir, the lamination comprising a reinforcing scrim between the two drug reservoir layers.

14. The method of manufacturing a transdermal drug applicator, according to claim 12, further comprising the step of laminating together said replaceable drug reservoir with another drug reservoir, the lamination comprising a semipermeable membrane between the two drug reservoir layers.

29. A method of manufacturing a transdermal drug applicator which is electrically activated, comprising the steps of:

a. applying conductive coated areas to one surface of a plastic substrate for use in said drug applicator;

b. folding by about 180°

portions of said conductive coated areas so as to provide electrical conductors leading to the other surface side of the drug applicator plastic substrate;

c. applying at least one occlusive adhesive dam to a surface of another substrate containing thereon a coated release agent;

d. adding at least one drug reservoir to said surface of said another substrate in areas not occupied by said occlusive adhesive dam;

e. applying at least one drug reservoir to a portion of at least one of said electrical conductors;

f. joining together in registration said plastic substrate and said another substrate to form a sandwiched construction in which said drug reservoirs and said occlusive adhesive dam are contained between said two substrates; and

g. applying a conformal cover having an adhesive coated surface over the folded plastic substrate so as to enclose and protect said transdermal drug applicator.

30. The method of manufacturing a transdermal drug applicator which is electrically activated according to claim 29, further comprising the step of applying an adhesive coating to the opposite surface of said plastic substrate.